10-Mar-2014 - Nearly 40% of the $51bn spent on clinical development last year was outsourced according to Quintiles, which has predicted continued growth for the CRO industry in documents outlining its second...
10-Mar-2014 - In a sign of further consolidation, CRO INC Research has acquired CRO MEK Consulting and will absorb its more than 40 employees based in the Middle East and north Africa.
06-Mar-2014 - Susan Thornton PhD, president and CEO of Celerion, broke down the company’s recent moves to partner with Seoul National University Hospital in an Outsourcing-Pharma.com exclusive.
05-Mar-2014 - European CRO KCR has registered two new entities in the UK and Germany, which adds to its presence in 18 countries in Europe as well as the US.
03-Mar-2014 - Scientists developing vaccines for potentially deadly diseases like influenza, SARS and HIV struggle to find a CRO with the right capabilities according to contractor TNO Triskelion.
03-Mar-2014 - Despite investor concerns about growth in R&D dollars for big pharma, CROs (contract research organizations) will benefit from the continued outsourcing, according to Citi analysts.
26-Feb-2014 - With a growing demand for comparative effectiveness data and questions on quality research persisting, Quintiles teamed with the National Pharmaceutical Council to develop and test a checklist to evaluate the...
25-Feb-2014 - A history of recreational drug use normally stops someone taking part in a trial, but growing US FDA pressure for data on a drug’s abuse potential has prompted CROs to...
25-Feb-2014 - CRO Pharmaceutical Product Development (PPD) and the Charité – Universitätsmedizin hospital in Berlin are collaborating to increase the volume of clinical trials conducted in Germany.
24-Feb-2014 - CRO consolidation has left market opportunities for providers who serve mid-size pharma, UK-based private equity firm Cinven says as it acquires Medpace.
24-Feb-2014 - Icon says it intends to continue its M&A strategy focusing on capabilities, geographies and technologies as it reports a robust 2013.
20-Feb-2014 - ICON Research gains a regulatory expert, plus new executives for Exco InTouch, Avillion and others.
19-Feb-2014 - Mid-tier pharma mergers and a shift to more complex trials will benefit broad-based CROs, whilst smaller outsourcing partners will be forced to consolidate, an industry report by Citi Research predicts.
18-Feb-2014 - WCCT Global has launched a patient recruitment platform it says speeds up recruitment time and can cut sponsor costs with a more targeted advertising campaign.
18-Feb-2014 - DaVita Clinical Research has formed a pact with Pyxant Labs where Pyxant will provide bioanalytical laboratory services for DCR's early-phase clinical trials.
17-Feb-2014 - Quintiles reported better-than-expected fourth-quarter results and analysts are predicting strong bookings and improved revenue growth through 2014.
13-Feb-2014 - CRO Chiltern International has partnered with Karolinska Development in Sweden, a life science investment company developing 21 drugs.
13-Feb-2014 - Kareus Therapeutics announced Wednesday that the US FDA has approved its Phase I clinical trial, which will be run by CRO Quintiles.
13-Feb-2014 - Phosphate Therapeutics has selected CRO Clinipace Worldwide to manage a Phase II trial in its late-stage nephrology program.
12-Feb-2014 - Parexel CEO Josef Von Rickenbach unloaded 50,000 shares of stock last Friday.
11-Feb-2014 - In an exclusive Q&A, new ACRO Chairman Ciaran Murray says conducting trials in countries such as China and India is critically important for speeding up drug development.
10-Feb-2014 - In an exclusive interview, Parexel’s president told Outsourcing-Pharma.com small pharma is increasing demand for CROs, commercialisation services are growing, and strategic partnerships are changing.
05-Feb-2014 - Covance has sold its high-complexity genomics laboratory to LabCorp as part of what an analyst says is decisive action to shed underperforming assets in its Early Development business.
04-Feb-2014 - CRO Ergomed Clinical Research has partnered with Ferrer to support a Phase IIa study of the insomnia drug Lorediplon.
04-Feb-2014 - The best of Twitter from this year's SCOPE - the Summit for Clinical Ops Executives - from February 4-6 at the Hyatt Regency in Miami, Florida. We've taken a sneak...